- Home
- Publications
- Publication Search
- Publication Details
Title
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 9, Pages 2073
Publisher
MDPI AG
Online
2021-04-26
DOI
10.3390/cancers13092073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells
- (2021) Paulina Kopa et al. MOLECULAR BIOLOGY REPORTS
- Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
- (2020) Jordan F Hastings et al. eLife
- Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
- (2020) Sarah Schoch et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6
- (2019) Maja T. Tomicic et al. ARCHIVES OF TOXICOLOGY
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Do Mutations Turn p53 into an Oncogene?
- (2019) Consuelo Pitolli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inherited DNA-Repair Defects in Colorectal Cancer
- (2018) Saud H. AlDubayan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers
- (2018) Roger K. Wolff et al. GENES CHROMOSOMES & CANCER
- Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair
- (2018) Ja-Hwan Seol et al. Nature Communications
- DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
- (2018) Xue Feng et al. Cancer Medicine
- Activity profile of the cisplatin analogue PN149 in different tumor cell lines
- (2018) Sarah Schoch et al. BIOCHEMICAL PHARMACOLOGY
- Improving anticancer activity towards colon cancer cells with a new p53-activating agent
- (2018) Liliana Raimundo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation
- (2018) Liang-Bo Hu et al. Frontiers in Oncology
- Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
- (2018) Amit Gupta et al. BIOMEDICINE & PHARMACOTHERAPY
- DNA mismatch repair and its many roles in eukaryotic cells
- (2017) Dekang Liu et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- Census and evaluation of p53 target genes
- (2017) M Fischer ONCOGENE
- DNA Hypomethylating Drugs in Cancer Therapy
- (2017) Takahiro Sato et al. Cold Spring Harbor Perspectives in Medicine
- Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
- (2017) Jarmila Herůdková et al. NEOPLASIA
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
- (2017) Rachel Pearlman et al. JAMA Oncology
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution
- (2016) Jinchuan Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
- (2015) Apostolia M Tsimberidou et al. Clinical Epigenetics
- γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
- (2014) Rebecca Rawlinson et al. BMC CANCER
- Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
- (2014) Christopher Bryant et al. BMC CANCER
- trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer
- (2014) Valentina Gandin et al. ChemMedChem
- Single molecule studies of DNA mismatch repair
- (2014) Dorothy A. Erie et al. DNA REPAIR
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
- (2014) Sarah Spreckelmeyer et al. MOLECULES
- Understanding nucleotide excision repair and its roles in cancer and ageing
- (2014) Jurgen A. Marteijn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design
- (2013) Ruth Thompson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of a Monofunctional Phenanthriplatin-DNA Adduct on RNA Polymerase II Transcriptional Fidelity and Translesion Synthesis
- (2013) Matthew W. Kellinger et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53
- (2013) M. A. Gadhikar et al. MOLECULAR CANCER THERAPEUTICS
- CHEK again: Revisiting the development of CHK1 inhibitors for cancer therapy
- (2013) S. McNeely et al. PHARMACOLOGY & THERAPEUTICS
- Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance
- (2013) Hong Shen et al. PLoS One
- MSH3 Mismatch Repair Protein Regulates Sensitivity to Cytotoxic Drugs and a Histone Deacetylase Inhibitor in Human Colon Carcinoma Cells
- (2013) Jae Myung Park et al. PLoS One
- Advances in Understanding the Complex Mechanisms of DNA Interstrand Cross-Link Repair
- (2013) C. Clauson et al. Cold Spring Harbor Perspectives in Biology
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer
- (2012) Nicola Margiotta et al. JOURNAL OF MEDICINAL CHEMISTRY
- XPA A23G polymorphism and susceptibility to cancer: a meta-analysis
- (2012) Jun Liu et al. MOLECULAR BIOLOGY REPORTS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile
- (2012) Ga Young Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational approaches targeting the p53 pathway for anti-cancer therapy
- (2011) Frank Essmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oxaliplatin: a review in the era of molecularly targeted therapy
- (2011) T. Alcindor et al. Current Oncology
- Clinical and pharmacokinetic evaluation of satraplatin
- (2011) Gury Doshi et al. Expert Opinion on Drug Metabolism & Toxicology
- The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog
- (2011) Guangan He et al. GYNECOLOGIC ONCOLOGY
- Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells
- (2011) Peyman Kabolizadeh et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual’s susceptibility to sporadic colorectal cancer
- (2011) Justyna Gil et al. MOLECULAR BIOLOGY REPORTS
- p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1
- (2011) S Y Nam et al. ONCOGENE
- p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
- (2011) Matthias Gutekunst et al. PLoS One
- Cisplatin resistance: Preclinical findings and clinical implications
- (2010) Beate Köberle et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
- (2010) Chi-Hui Tang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Mammalian nucleotide excision repair proteins and interstrand crosslink repair
- (2010) Richard D. Wood ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Transcription Inhibition by Platinum−DNA Cross-Links in Live Mammalian Cells
- (2010) Wee Han Ang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- Photoaffinity Labeling Reveals Nuclear Proteins That Uniquely Recognize Cisplatin−DNA Interstrand Cross-Links
- (2009) Guangyu Zhu et al. BIOCHEMISTRY
- Rapid DNA Double-Strand Breaks Resulting from Processing of Cr-DNA Cross-Links by Both MutS Dimers
- (2009) M. F. Reynolds et al. CANCER RESEARCH
- Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling
- (2009) Ryan P. Topping et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors
- (2009) Friedemann Honecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of transcription by platinum antitumor compounds
- (2009) Ryan C. Todd et al. Metallomics
- Checkpoint Signaling from a Single DNA Interstrand Crosslink
- (2009) Merav Ben-Yehoyada et al. MOLECULAR CELL
- Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines
- (2008) Paul Noordhuis et al. BIOCHEMICAL PHARMACOLOGY
- Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines
- (2008) Nadia Gambi et al. BIOCHEMICAL PHARMACOLOGY
- Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology
- (2008) Sarah C Shuck et al. CELL RESEARCH
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
- (2008) H. Choy et al. CLINICAL CANCER RESEARCH
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis
- (2008) E. Avdievich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
- Unique Properties of DNA Interstrand Cross-Links of Antitumor Oxaliplatin and the Effect of Chirality of the Carrier Ligand
- (2007) Jana Kasparkova et al. CHEMISTRY-A EUROPEAN JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More